Pfizer (PFE) Exchange Rate Effect (2009 - 2026)

Pfizer (PFE) has 18 years of Exchange Rate Effect data on file, last reported at $19.0 million in Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at $19.0 million, up 371.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.0 million (up 174.44% YoY), and the FY2025 annual result was $41.0 million, up 162.12% from the prior year.
• Exchange Rate Effect grew to $19.0 million in Q1 2026 per PFE's latest filing, from $5.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $41.0 million in Q2 2025 and troughed at -$139.0 million in Q4 2022.
• A 5-year average of -$17.9 million and a median of -$5.0 million in 2023 frame the typical range for Exchange Rate Effect.
• The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect plunged 1420.0% in 2022, then jumped 371.43% in 2026.
• A 5-year view of Exchange Rate Effect shows it stood at -$139.0 million in 2022, then surged by 99.28% to -$1.0 million in 2023, then sank by 3600.0% to -$37.0 million in 2024, then soared by 113.51% to $5.0 million in 2025, then jumped by 280.0% to $19.0 million in 2026.
• Business Quant data shows PFE's Exchange Rate Effect at $19.0 million in Q1 2026, $5.0 million in Q4 2025, and $2.0 million in Q3 2025.